Accuray/ARAY

$1.63

-2.39%
-
1D1W1MYTD1YMAX

About Accuray

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.

Ticker

ARAY

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Suzanne Winter

Employees

1,024

Headquarters

Madison, United States

Accuray Metrics

BasicAdvanced
$168M
Market cap
-
P/E ratio
-$0.22
EPS
1.42
Beta
-
Dividend rate
$168M
1.42267
$4.30
$1.51
597K
1.582
0.778
404.679
422.322
-0.39%
-4.58%
-44.87%
-7.84%
0.389
4.083
-2%
-101.52%
5.34%

What the Analysts think about Accuray

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 4 analysts.
268.1% upside
High $7.00
Low $5.00
$1.63
Current price
$6.00
Average price target

Accuray Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-6.23% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$101M
-5.69%
Net income
-$6.3M
-34.38%
Profit margin
-6.23%
-30.39%

Accuray Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 380%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-$0.03
-$0.03
-$0.10
-$0.06
-
Expected
$0.01
-$0.05
-$0.05
-$0.01
$0.03
Surprise
-400%
-40%
100%
380%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Accuray stock?

Accuray (ARAY) has a market cap of $166M as of May 18, 2024.

What is the P/E ratio for Accuray stock?

The price to earnings (P/E) ratio for Accuray (ARAY) stock is 0 as of May 18, 2024.

Does Accuray stock pay dividends?

No, Accuray (ARAY) stock does not pay dividends to its shareholders as of May 18, 2024.

When is the next Accuray dividend payment date?

Accuray (ARAY) stock does not pay dividends to its shareholders.

What is the beta indicator for Accuray?

Accuray (ARAY) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Accuray stock price target?

The target price for Accuray (ARAY) stock is $6, which is 268.1% above the current price of $1.63. This is an average based on projections from 4 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Accuray stock

Buy or sell Accuray stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing